| Χρονικό πλαίσιο | Προβλεπόμενη τιμή | Το παρελθόν | Ιστορικός | Διορατικότητα |
|---|---|---|---|---|
| Αύριο | $7.95 ▲ +1.41% | Εχθές | $7.79 ▼ -0.59% | Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%. |
Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%. | ||||
| Εβδομάδα | $8.18 ▲ +4.40% | Την περασμένη εβδομάδα | $7.70 ▼ -1.85% | The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick. |
The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick. | ||||
| Μήνας | $8.57 ▲ +9.37% | τον περασμένο μήνα | $7.53 ▼ -3.94% | The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Ετος | $9.16 ▲ +16.82% | Πέρυσι | $7.29 ▼ -7.07% | The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Χρόνια | $10.53 ▲ +34.29% | Πριν 5 Χρόνια | $6.71 ▼ -14.40% | The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Δείκτης | Αξία | Σύνθημα |
|---|---|---|
| Price | $7.84 | Mid |
| Daily Change | -4.16% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $7.84 | Daily Change | -4.16% |
| Market Cap | $778.49M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.